Table 2.
Quality of the evidence, in aggregate, supporting single-dose doxycycline for Lyme disease prophylaxis.
| No. of studies | Limitations | Imprecision | Inconsistency | Indirectness | Quality |
|---|---|---|---|---|---|
| 1 | Inappropriate surrogate (EM) Insufficient duration of observation Insufficient reporting of negative treatment-associated outcomes |
Few events Wide CI Unsupported assumption regarding outcomes in dropouts |
Non-replicated in humans Inconsistent with animal model |
Not applicable to patients bitten by species other than Ixodes scapularis
Not applicable to patients exposed to multiple tick-borne diseases Efficacy not applicable to other antibiotics Effectiveness findings applicable to prevention of EM only and not other, non-EM presentations |
Very low |
EM: Erythema migrans.